Option chain shows key data for bioAffinity Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for bioAffinity Technologies.

bioAffinity Technologies (NASDAQ:BIAF) Stock, Option Chain

bioAffinity Technologies

bioAffinity Technologies, Inc. - Common Stock

Overview

News

Earnings

Guidance

Analyst Ratings

Insider Trades

Short Interest

Stock Report

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Comments

bioAffinity Technologies Option Chain

No option chain data available. Please try again later